Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (411-420 of 741) with videos related to

Pageof 75
Sort By:
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
JAMA Neurology|March 29, 2016
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer DiseaseRawan Tarawneh, Gina D'Angelo, Dan Crimmins, et al.
Plos One|May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variationRichard J Perrin, Jacqueline E Payton, James P Malone, et al.
EMBO Molecular Medicine|January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseAnne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Molecular Neurodegeneration|October 21, 2018
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanismQingyi Ma, Zhen Zhao, Abhay P Sagare, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 18, 2016
The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 MiceMolly Stanley, Shannon L Macauley, Emily E Caesar, et al.
The Journal of Clinical Investigation|May 5, 2015
Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivoShannon L Macauley, Molly Stanley, Emily E Caesar, et al.
Archives of Neurology|September 14, 2011
Cerebrospinal fluid biomarkers, education, brain volume, and future cognitionCatherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Molecular Neurodegeneration|June 5, 2014
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2Jason D Ulrich, Mary Beth Finn, Yaming Wang, et al.
The Journal of Experimental Medicine|March 5, 2024
Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathyDanira Toral-Rios, Justin M Long, Jason D Ulrich, et al.
Pageof 75

Showing results (411-420 of 741) with videos related to

Sort By:
Pageof 75
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
JAMA Neurology|March 29, 2016
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer DiseaseRawan Tarawneh, Gina D'Angelo, Dan Crimmins, et al.
Plos One|May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variationRichard J Perrin, Jacqueline E Payton, James P Malone, et al.
EMBO Molecular Medicine|January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseAnne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Molecular Neurodegeneration|October 21, 2018
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanismQingyi Ma, Zhen Zhao, Abhay P Sagare, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 18, 2016
The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 MiceMolly Stanley, Shannon L Macauley, Emily E Caesar, et al.
The Journal of Clinical Investigation|May 5, 2015
Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivoShannon L Macauley, Molly Stanley, Emily E Caesar, et al.
Archives of Neurology|September 14, 2011
Cerebrospinal fluid biomarkers, education, brain volume, and future cognitionCatherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Molecular Neurodegeneration|June 5, 2014
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2Jason D Ulrich, Mary Beth Finn, Yaming Wang, et al.
The Journal of Experimental Medicine|March 5, 2024
Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathyDanira Toral-Rios, Justin M Long, Jason D Ulrich, et al.
Pageof 75